Insider Transactions
| Date | Name | Title | Filing | Type | Shares Traded | Price Range | Total Held |
|---|---|---|---|---|---|---|---|
| Apr 01, 2021 | Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 5,726 | -- | -- | |
| Sep 14, 2020 | SVP/GM, VIT | Form 3 | Initial Statement of Beneficial Ownership of Securities | 17,640 | -- | -- | |
| Sep 14, 2020 | SVP/GM, VIT | Form 3 | Initial Statement of Beneficial Ownership of Securities | 11,782 | -- | -- | |
| Sep 14, 2020 | SVP/GM, VIT | Form 3 | Initial Statement of Beneficial Ownership of Securities | 50,000 | -- | -- | |
| Sep 14, 2020 | SVP/GM, VIT | Form 3 | Initial Statement of Beneficial Ownership of Securities | 12,000 | -- | -- | |
| Aug 06, 2019 | Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 6,650 | -- | -- | |
| Jul 16, 2019 | Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 6,650 | -- | -- | |
| Jul 16, 2019 | Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 7,000 | -- | -- | |
| Jul 12, 2019 | SVP/GM, Vascular Access | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 6,103 | -- | -- | |
| Jul 12, 2019 | Director, President and CEO | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 250,000 | -- | -- |
For recent transactions, including derivative transactions, see our Section 16 SEC filings page.